G. Audibert et al., EFFECT OF THE H-1 BLOCKER D-CHLORPHENIRAMINE ON CEREBRAL BLOOD-FLOW IN THE CONSCIOUS DOG DURING NORMOCAPNIC HYPOXIA, Clinical physiology, 18(1), 1998, pp. 27-33
The mechanism causing cerebral vasodilatation during hypoxia remains u
nclear. A role for histamine is suspected because H-2 receptor-blockin
g drugs blunt the hypoxia-induced increase in cerebral blood flow (CBF
). Moreover, in vitro blockade of H-1 receptors by chlorpheniramine de
creases the vasodilatation of cerebral arteries that is induced by his
tamine. The present study tested the hypothesis that an H-1 receptor b
locker (d-chlorpheniramine) would have a similar effect in vivo during
hypoxia. Isocapnic hypoxia (inspired oxygen fraction, FIO2 = 0.10; in
spired carbon dioxide fraction, FICO2 = 0.035) was induced in 16 consc
ious dogs randomly divided into two groups: eight dogs received saline
intravenously (controls) at time 0 (normoxia) and after 2 h and 4 h h
ypoxia, and the other eight dogs received d-chlorpheniramine intraveno
usly (0.5 mg kg(-1)) to block the H-1 receptors. Regional CBF was meas
ured by the radioactive microspheres technique 15 min after each injec
tion of d-chlorpheniramine or saline. In the control group, CBF increa
sed during hypoxia in all regions of the brain. In the d-chlorpheniram
ine group, total CBF increased similarly after 2 h of hypoxia. After 4
h of hypoxia, the increase was limited, especially in the pens, cereb
ral peduncles, hippocampus, hypothalamus, thalamus, and occipital lobe
s (six out of 12 studied regions). It is concluded that the H-1 blocke
r d-chlorpheniramine did not strongly inhibit the increase in CBF duri
ng hypoxia. After cumulative doses, however, as in the fourth hour of
hypoxia, the increase in total CBF was limited.